Today: 11 June 2026
Micron stock price near $400: MU investors brace for Fed decision and Big Tech earnings

Micron stock price near $400: MU investors brace for Fed decision and Big Tech earnings

New York, Jan 25, 2026, 16:28 ET — Market closed.

  • Micron shares closed Friday at $399.65, ticking up roughly 0.5% from the previous session.
  • Wall Street continues to highlight tight supply and climbing prices for memory chips used in AI servers.
  • Next up: the Fed’s rate decision on Jan. 28 and a packed week of Big Tech earnings.

Micron Technology Inc shares closed the week just shy of $400, last seen at $399.65 on Friday. That’s roughly a 0.5% gain from the previous session as U.S. markets head into the weekend shutdown. AI-related chip stocks have a busy schedule looming.

This shift is significant as memory and data-storage stocks emerge as a new hotspot in the AI sector, drawing funds that once flowed predominantly to major tech giants. The Financial Times reports that AI infrastructure spending is expected to exceed $500 billion this year, boosting firms like Micron, Western Digital, and SK Hynix.

Micron is right in the thick of that spending: its chips power the servers running and training AI models. If cloud budgets falter or interest rates shift, the stock can take a sharp turn—even without any news from the company itself.

Analyst notes remain sharp. TD Cowen’s Krish Sankar, who recently raised his Micron price target to $450, pointed to “worsening rather than improving” memory shortages. He highlighted rising DRAM and NAND prices as a factor pushing buyers toward longer supply contracts. Sankar also suggested Micron could “continue to outperform” short term, with “cleanroom constraints” capping how fast supply expands. Finviz

In its December update, Micron backed up the tight supply narrative with numbers. The chipmaker projected second-quarter adjusted earnings of $8.42 per share, plus or minus 20 cents, and plans to boost capital spending to $20 billion in 2026, according to Reuters. Micron stands among the top three suppliers of high-bandwidth memory (HBM)—a stacked DRAM variant used in AI chips—alongside Samsung Electronics and SK Hynix, the report noted.

HBM is the product investors can’t stop watching. It may not dominate memory by volume, but it offers higher margins and tightens supply quickly as AI chip production ramps up.

The catch here is one that’s all too familiar in memory markets: cycles shift. Should supply ramp up faster than anticipated, or if AI budgets tighten after audits, pricing power could slip—and the stock might lose gains just as fast.

This week’s lineup is packed, pushing investors to weigh their bets on the fly. The Fed’s rate decision lands Wednesday, along with Chair Jerome Powell’s press briefing. Earnings from Microsoft, Meta, and Tesla also hit that day, while Apple reports Thursday, noted.

For Micron, these reports carry less weight for their immediate earnings and more as indicators for capex — specifically, whether top customers continue expanding data centers and if AI demand remains strong for high-end memory.

U.S. markets reopen Monday, with traders eyeing the Federal Open Market Committee meeting scheduled for Jan. 27-28. The rate decision on Wednesday, Jan. 28, is expected to shape risk appetite, especially impacting crowded AI semiconductor names like Micron.

Stock Market Today

  • Ideaya Biosciences Stock Drops 10% Amid $300M Fundraising Despite Bullish Outlook
    June 10, 2026, 10:30 PM EDT. Shares of Ideaya Biosciences ($IDYA) fell 10% to around $27 following the announcement of a $300 million stock offering priced at $27 per share, diluting existing shareholder value. The biotech firm had surged 13% earlier due to promising oncology trial results presented at ASCO. Analysts from Citizens reaffirmed a Market Outperform rating and a $45 target, citing robust pipeline developments and collaborations, including a deal with Roche on a novel oncology drug combination. Positive clinical data showed a 37% response rate in uveal melanoma, substantially outperforming standard care. The cash raise aims to advance multiple cancer trials, ensuring a solid financial runway despite near-term stock pressure from dilution.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Nestle stock faces Monday test after France probes baby deaths tied to recalled formula
Previous Story

Nestle stock faces Monday test after France probes baby deaths tied to recalled formula

Zhongji Innolight (300308.SZ) stock: China’s new fund-favorite faces a Monday test after a 5.8% slide
Next Story

Zhongji Innolight (300308.SZ) stock: China’s new fund-favorite faces a Monday test after a 5.8% slide

Go toTop